Headline
The latest stories from AHA Today.
In a letter submitted to the House Energy and Commerce Subcommittee on Oversight and Investigations for a hearing on challenges implementing value-based and alternative payment models under the Medicare Access and CHIP Reauthorization Act of 2015, AHA encouraged certain statutory and regulatory…
A bipartisan group of 87 representatives urged the Centers for Medicare & Medicaid Services to reevaluate its proposed payment update for the inpatient prospective payment system for fiscal year 2024, expressing concern that the proposed update does not accurately reflect the current costs of…
Waleed Javaid, M.D., director of infection prevention and control at Mount Sinai Health System in New York, shares successful strategies for eliminating healthcare-associated infections.
The Substance Abuse and Mental Health Services Administration today issued an advisory offering evidence-based resources to help clinicians assess and treat mental health symptoms and conditions associated with Long COVID, from fatigue and sleep disturbances to depression, anxiety and post-…
In a statement submitted to the House Education and Workforce Subcommittee on Health, Employment, Labor, and Pensions for a hearing today on competition and transparency in health care, AHA said mergers and acquisitions are important tools that some hospitals use to lower costs and…
The House Energy and Commerce Subcommittee on Health today held a hearing on legislation to reauthorize and build on the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities (SUPPORT) Act of 2018.
Cone Health partnered with Guilford County in 2021 to create the first behavioral health urgent care center in North Carolina, quickly reducing hospital stays and emergency department visits for behavioral health while shrinking health disparities.
Louisiana Gov. John Bel Edwards June 19 signed into law state-level protections developed by the AHA. The Louisiana law prevents drug companies from denying, restricting, prohibiting or interfering with the acquisition or delivery of a 340B drug at a contract pharmacy.
June 22 at noon ET, the Department of Health and Human Services’ Office of Climate Change and Health Equity will host a webinar to review the Inflation Reduction Act’s tax incentives to reduce emissions in the health sector, including direct payment opportunities for not-for-profit hospitals and…
The Food and Drug Administration June 20 released guidance on a new voluntary pilot program intended to improve certain laboratory-developed tests used to identify patients for treatment with certain oncology drug products